|
Smallpox vaccinations: A shot in the dark
By Marilyn Elias, USA TODAY
The threat of bioterrorism is not high enough to
justify preventive smallpox vaccination of children and teenagers, U.S.
pediatricians say in a policy statement today.
Vaccinations should be reconsidered if new
evidence suggests bioterrorism is more likely or if safer vaccines are
developed, says the American Academy of Pediatrics (AAP).
Smallpox vaccines "are not nearly as safe as
other vaccinations we routinely use, and they're for diseases that are
around, unlike smallpox," says Robert Baltimore of Yale Medical School,
co-author of the policy.
The influential AAP is weighing in as the federal
government considers who should be vaccinated in anticipation of a
bioterrorist attack.
Top federal scientists Friday recommended making
vaccine available to any American who wants it after medical and
emergency workers are immunized.
The new AAP policy favors a "ring" approach —
isolating those who develop smallpox and immunizing people around them —
rather than giving shots before an attack to anyone who volunteers.
A key concern about a "voluntary," preventive
plan is that immunized people develop a blister that can transmit the
virus to others who haven't volunteered for shots. "There is no such
thing as a truly voluntary plan," Baltimore says.
Routine smallpox vaccination ended in 1972. The
disease has been eradicated, but fears persist that terrorists have
obtained stocks of the virus.
Estimates on adverse reactions from the vaccine,
which are based on studies in the 1960s, could be low because more
Americans now have weak immune systems, Baltimore says. Those with
weaker immune function are most likely to be harmed by the vaccine or
from contact with immunized people.
Children pose special problems. The United States
has stored vaccine that can be diluted and that will work for adults if
there's a mass immunization program. But the diluted dosage needed for
children is unknown, Baltimore says.
The government has plans to test that vaccine on
children in the Cincinnati and Los Angeles areas. But it's unknown when
or even if the study will start, says Anthony Fauci, director of the
National Institute of Allergy and Infectious Diseases. Experts will
testify on the risks and benefits of the study for kids at a public
meeting in November called by the Department of Health and Human
Services, Fauci says. The HHS secretary "will have to approve the
trial," he says.
Although some parents are worried, most aren't
clamoring for their kids to get smallpox shots, according to an informal
USA TODAY check with children's doctors. The scene is nothing like last
year's anthrax scare, when pediatricians were swamped with demands for
antibiotics and smallpox vaccines.
"It's not on their radar screen right now," says
pediatrician Garry Gardner of Darien, Ill.
Loraine Stern, who treats middle-class families
in Newhall, Calif., says: "Parents are concerned; they're asking about
it. But they're not acting cuckoo like they were last fall."
|